Share This Page
Suppliers and packagers for indocin
✉ Email this page to a colleague
indocin
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Zyla | INDOCIN | indomethacin | SUSPENSION;ORAL | 018332 | NDA | Zyla Life Sciences US LLC | 69344-101-01 | 1 BOTTLE, GLASS in 1 CARTON (69344-101-01) / 237 mL in 1 BOTTLE, GLASS | 2019-02-04 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers for the Pharmaceutical Drug: Indocin
Overview of Indocin and Its Market
Indocin, the brand name for indomethacin, is a nonsteroidal anti-inflammatory drug (NSAID) commonly prescribed to reduce inflammation, pain, and fever associated with conditions like rheumatoid arthritis, osteoarthritis, gout, and various musculoskeletal disorders. Since its approval by the FDA in 1965, indomethacin has established itself as a critical therapeutic agent with widespread global market demand.
The supply chain for indomethacin comprises a diverse network of manufacturers, bulk drug suppliers, and formulation companies spanning multiple countries. Ensuring the availability of high-quality raw materials and the manufacturing of consistent, compliant formulations is vital for pharmaceutical companies, healthcare providers, and regulatory authorities.
Major International Suppliers of Indomethacin API
1. Indian Manufacturers
India remains a dominant player in the global API (Active Pharmaceutical Ingredient) manufacturing landscape due to its cost-effective production, robust regulatory environment, and extensive pharmaceutical infrastructure.
a) Zydus Cadila
- Overview: A significant Indian pharmaceutical company, Zydus Cadila produces indomethacin API for diverse markets.
- Capabilities: Full-spectrum API manufacturing, quality assurance protocols aligned with global standards.
- Certifications: WHO-GMP, USFDA, and EU-GMP approvals.
b) Aarti Industries
- Overview: Specializes in the production of diverse specialty chemicals, including NSAIDs like indomethacin.
- Supply Scope: Supplies both bulk APIs and intermediates.
- Market Presence: exporting to North America, Europe, Asia, and Africa.
c) Sandoz (Novartis division)
- Overview: A major global generics manufacturer with API manufacturing facilities in India.
- Notes: Offers indomethacin APIs that adhere to strict regulatory standards.
2. Chinese Manufacturers
China is a key supplier of pharmaceutical APIs, including indomethacin, owing to its large-scale manufacturing capabilities and competitive pricing.
a) Zhejiang Hisun Pharmaceutical Co., Ltd.
- Overview: One of China's leading pharmaceutical enterprises.
- Capabilities: Produces a broad range of APIs, including NSAIDs.
- Certifications: GMP compliant; exporting globally.
b) Ruihua Pharmaceutical Co., Ltd.
- Overview: Specializes in NSAID APIs with consistent supply capabilities.
- Quality Standards: Meets international regulatory standards for API manufacturing.
3. European and U.S. Suppliers
While less prominent than Indian and Chinese producers, some companies in Europe and the U.S. supply indomethacin APIs, primarily for high-end markets requiring strict regulatory compliance.
a) Evonik Industries (Germany)
- Overview: Produces specialty chemicals and pharmaceutical intermediates.
- Role: Supplies pharmaceutical intermediates and custom synthesis services which may include indomethacin derivatives.
b) North American Bulk API Suppliers
- The U.S. and Canadian companies involved in generic API production sometimes contract with manufacturing facilities in India or China to meet local demand.
Key Considerations in Supplier Selection
Regulatory Compliance and Quality Assurance
Suppliers must hold GMP certifications from recognized bodies such as the USFDA, EMA, or WHO. Quality assurance measures, stability data, and batch consistency underpin regulatory approval and market acceptance.
Supply Chain Reliability
Long-term partnerships depend on consistent supply, capacity for large-volume orders, and contingency planning for supply disruptions.
Price Competitiveness
The global API market is price-sensitive, with Indian and Chinese suppliers offering competitive rates. However, stakeholders must balance cost with quality and regulatory compliance.
Environmental and Ethical Standards
Sustainable manufacturing practices and adherence to environmental regulations increasingly influence supplier selection, especially with the rising emphasis on ESG criteria.
Regional Market Dynamics and Trends
India's Leading Role
India dominates the indomethacin API market, providing approximately 40-50% of global API supply.[1] Its favorable regulatory environment, high manufacturing standards, and cost advantages make it the preferred sourcing region for many pharmaceutical firms.
Chinese API Manufacturing Expansion
China's API sector continues expanding, with investments in R&D and quality improvements aligning with stricter international standards, though concerns over IP rights and regulatory consistency remain.
Regulatory Impact
Stringent regulations, such as the USFDA's drug master files (DMFs) and audits, influence supplier qualification processes. Companies seek API suppliers with proven regulatory track records to avoid market access issues.
Future Outlook and Strategic Sourcing
The global trend toward diversification of supply chains gained momentum during the COVID-19 pandemic, prompting pharmaceutical companies to reassess their reliance on traditional countries. Diversifying suppliers for indomethacin ensures resilience against geopolitical tensions, supply chain disruptions, and regulatory changes.
Emerging markets and partnerships with Contract Manufacturing Organizations (CMOs) are increasingly part of strategic procurement policies. Additionally, advancements in green chemistry and sustainable manufacturing practices may influence future supplier evaluations.
Key Takeaways
- Indian API manufacturers such as Zydus Cadila and Aarti Industries are leading global suppliers of indomethacin, offering quality and cost advantages.
- Chinese producers like Zhejiang Hisun Pharmaceutical are instrumental in meeting global demand, especially for cost-sensitive markets.
- Regulatory compliance, quality standards, and supply reliability are critical criteria for sourcing indomethacin APIs.
- Diversification of supply chains is an emerging strategic priority to mitigate geopolitical and pandemic-related risks.
- International certifications and consistent batch quality underpin successful supplier relationships and market access.
FAQs
1. Who are the top global suppliers of indomethacin API?
Indian companies like Zydus Cadila and Aarti Industries lead, alongside Chinese suppliers such as Zhejiang Hisun Pharmaceutical. These manufacturers have extensive manufacturing capacities and regulatory certifications.
2. What should pharmaceutical companies consider when choosing an indomethacin supplier?
Key factors include regulatory compliance (GMP certifications), consistent quality, supply reliability, cost competitiveness, and adherence to environmental standards.
3. Are generic formulations of indomethacin available from multiple suppliers?
Yes, numerous manufacturers globally produce indomethacin generics, enabling pharmaceutical companies to diversify sourcing and reduce supply chain risks.
4. How does regulatory approval impact supplier selection?
Suppliers with stringent regulatory certifications (e.g., USFDA, EMA, WHO-GMP) streamline approval processes and ensure market access across major regions.
5. Are there sustainability concerns associated with indomethacin API manufacturing?
Environmental impact is increasingly scrutinized; suppliers adopting green chemistry practices and environmentally compliant facilities are favored in responsible sourcing strategies.
Sources
[1] Indian Pharmaceutical Association. "India's API Market Overview," 2022.
More… ↓
